During the month of March, the Blood Research Institute/Nadeene Brunini Center at Saint Michael’s Medical Center is marking Bleeding Disorders Awareness Month by bringing awareness of bleeding disorders to the public and healthcare professionals.
First designated as Hemophilia Awareness Month by President Ronald Regan in 1986, the name was changed in 2016 to Bleeding Disorders Awareness Month to increase awareness of inheritable blood and bleeding disorders
Von Willebrand Disease (VWD) is the most common bleeding disorder, affecting approximately one million Americans. Both men and women are affected equally. Hemophilia is a rare bleeding disorder affecting about 20,000 people in the United States. Hemophilia is an X-linked disorder that affects mostly males. It is caused by a lack of clotting factor VIII or IX. While there is no cure, people can lead effective lives with treatment.
The Blood Research Institute at Saint Michael’s is a federally recognized hemophilia treatment center delivering multidisciplinary collaborative care to adult patients with bleeding disorders. Under the leadership of expert hematologist Dr. Gunwant Guron, the Institute aims to provide comprehensive individualized treatment and care to patients and family members.
The team includes board certified hematology/oncology physicians, Dr. Hamid Shaaban, Dr Andreas Savopoulos and Dr. Stephen Abo. The team includes nurses, social worker, infectious disease and physical therapy.
The treatment center also has a state-of-the-art coagulation laboratory. It also provides care and treatment for patients with thrombosis and other blood disorders. The Institute’s goal is to provide compassionate and innovative treatment to our patients to maintain health and improve quality of life.
To make an appointment with a hematologist at the Blood Research Institute, call 973-877-5340.